News

All
07. 04. 26

Zynnon sponsor at ESCMID – European Society of Clinical Microbiology and Infectious Diseases 2026
06. 11. 25

Zynnon Launches Groundbreaking Diagnostic Platform for Rapid Detection of Bloodstream Infections
Dr Philippe Gadal
20. 10. 24

Zynnon welcomes Dr. Philippe Gadal as an Advisor
Image PR Bioaster Zynnon
26. 09. 24

BIOASTER collaborates with ZYNNON to advance VOC-based detection and identification
Dr. Mark Miller
12. 09. 24

Zynnon welcomes Dr. Mark Miller as an Advisor
20. 12. 23

Transforming the diagnostic of respiratory infections: Zynnon hits a key milestone with its breakthrough solution
13. 09. 23

Revolutionizing Respiratory Infection Detection: Zynnon’s Breakthrough Clinical Study Yields Promising Results
27. 06. 22

Zynnon raises CHF800,000 in seed funding to detect the risk of respiratory infection transmission
22. 06. 22

Zynnon in the news
23. 05. 22

Zynnon receives Innosuisse grant to detect risk of respiratory infection transmission
28. 02. 22

Zynnon welcomes Prof. Dr. med. Didier Guillemot as an Advisor
10. 02. 22

Zynnon welcomes Prof Suzanne Suggs as an Advisor
03. 02. 22

Zynnon joins Microsoft for Startups
16. 12. 21

Zynnon and tilia Stiftung collaborate to validate Zynnon’s solution for Nursing Homes
08. 12. 21

Zynnon: Interview with the founder
16. 08. 21

Zynnon signs a partnership with Swisscom
05. 07. 21

Zynnon selected for the InvestHorizon Accelerator
07. 04. 21

Zynnon welcomes Prof. Dr. Christoph Schankin as Chief Medical Officer
24. 02. 21

Zynnon and CSEM collaborate to develop a new smart thermometer
24. 02. 21

Zynnon enters the Innosuisse ecosystem
Load more

We serve the Clinical Diagnostics Microbiology market

Enhancing Gold Standard pathogen cultures through gas biomarkers

Discover Zynnon

We innovate for smarter health.